sir. is it him? the fourth - chancellor in four months. his sir. is it him? the fourth chancellor in four months. his first act was to ditch liz truss plans. we will not be able to cut taxes as quickly as we want to and some will have to go up. we quickly as we want to and some will have to go unm quickly as we want to and some will have to go up. we now at the mercy ofthe have to go up. we now at the mercy of the mighty have to go up. we now at the mercy of the mighty markets? have to go up. we now at the mercy of the mighty markets? he - have to go up. we now at the mercy of the mighty markets? he wouldn t of the mighty markets? he wouldn t be the only one to wonder what on earth is going on. so we have one big question this morning. who is really in charge? this morning, we ll hear from the man tasked with saving the economy and liz truss premiership her new chancellor, jeremy hunt. and, as labour keep hold of their huge lead in the polls, i ll be speaking to ma
cure, patients survival? when do you believe this might be cancer vaccines might be something that many patients around the world would be able to access? we believe that this will happen definitely even on a bolder scale before 2030. the success of the technology you ve worked on for years was proven to the world with your covid vaccine. could a positive of the pandemic actually be that you find a way of defeating cancer more quickly than you otherwise would have done? yes, this is actually very interesting. what we have developed over decades in cancer, for cancer vaccine development, has been the tailwind for developing the covid 19 vaccine, and now the covid 19 vaccine and our experience in developing it gives back to our cancer work. we have learned how to better and faster manufacture vaccines,
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
Tonix Pharmaceuticals Holding Corp.December 23, 2020 GMT
Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19
CHATHAM, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has completed the purchase of an approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and commercial scale manufacturing facility. In September 2020, Tonix completed the purchase of a 40,000 square foot facility in Massachusetts to house its new Advanced Development Center (ADC) for accelerated development and manufacturing of vaccines for clinical trials. Both the Montana and Massachusetts facilities